CVR: 41319208
Pephexia Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Keld Fogtmann Fosgerau. The company is owned by Fogtmann Fosgerau Holding ApS and Andrew Justin Stewart Coats. In 2025, the company reported a gross profit of DKK -179,735 and a net result of DKK -4,440,533 compared with DKK -5,320,870 the year before. Equity amounted to DKK -19,747,345.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileVirksomhedens formål er forskning og udvikling af lægemidler samt anden dermed beslægtet virksomhed efter direktionens skøn.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.053 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Pephexia Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -179,735, and the net result was DKK -4,440,533.
Contact info changed: new phone: 50910969, new email: [email protected], new website: www.pephexia.com (May 28, 2026).
As of May 27, 2026, Ricki Boye has joined the board of directors of Pephexia Therapeutics ApS.
Contact info changed: new phone: 50910969, new email: [email protected], new website: www.pephexia.com (May 15, 2026).
Contact info changed: new phone: 50910969, new email: [email protected], new website: www.pephexia.com (April 1, 2026).
Contact info changed: new phone: 50910969, new email: [email protected], new website: www.pephexia.com (March 31, 2026).
Pephexia Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -2,085,438, and the net result was DKK -5,320,870.
Pephexia Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -3,212,128, and the net result was DKK -5,439,731.
As of May 22, 2024, Stefan Dietmar Anker has joined the board of directors of Pephexia Therapeutics ApS.
As of May 22, 2024, Yann Albert André Colardelle has left the board of directors of Pephexia Therapeutics ApS.
Pephexia Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -5,266,259, and the net result was DKK -6,677,466.
As of December 16, 2022, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Pephexia Therapeutics ApS.
As of November 22, 2022, Fogtmann Fosgerau Holding ApS is registered as an owner of Pephexia Therapeutics ApS with an ownership share of 50%.
As of July 7, 2022, Keld Fogtmann Fosgerau has joined the board of directors of Pephexia Therapeutics ApS.
As of July 7, 2022, Anders Mørkeberg Hinsby has joined the board of directors of Pephexia Therapeutics ApS.
As of July 6, 2022, Keld Fogtmann Fosgerau has left the board of directors of Pephexia Therapeutics ApS.
Pephexia Therapeutics ApS has published its annual report for 2021. Revenue came to DKK 626,000, and the net result was DKK -4,532,328.
Pephexia Therapeutics ApS has published its interim report for the period April 24, 2020 – December 31, 2020.
As of November 2, 2020, Keld Fogtmann Fosgerau has joined the board of directors of Pephexia Therapeutics ApS.
As of November 2, 2020, Yann Albert André Colardelle has joined the board of directors of Pephexia Therapeutics ApS.
As of November 2, 2020, Mats Peter Blom has joined the board of directors of Pephexia Therapeutics ApS.
As of November 2, 2020, Andrew Justin Stewart Coats has joined the board of directors of Pephexia Therapeutics ApS.
As of November 2, 2020, is registered as an owner of Pephexia Therapeutics ApS with an ownership share of 5%.
As of April 24, 2020, Keld Fogtmann Fosgerau is registered as director of Pephexia Therapeutics ApS.
Pephexia Therapeutics ApS was founded on April 24, 2020.
Companies in the same industry and area
CVR 40766383
CVR 46613139
CVR 34688605
CVR 44504332
CVR 43917897